Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Asarina Pharma AB (publ)

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 108 More Arrow 414 More Arrow 513
Earnings before taxes -14,768 More Arrow -14,026 Less Arrow -37,348
EBITDA -14,402 More Arrow -13,509 Less Arrow -36,957
Total assets 6,156 More Arrow 15,945 More Arrow 29,609
Current assets 5,366 More Arrow 14,827 More Arrow 28,167
Current liabilities 4,486 Less Arrow 2,133 More Arrow 8,989
Equity capital 1,670 More Arrow 13,812 More Arrow 20,620
- share capital 5,734 Less Arrow 5,354 Less Arrow 4,570
Employees (average) 5 Equal arrow 5 More Arrow 6

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 27.1% More Arrow 86.6% Less Arrow 69.6%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -238.1% More Arrow -85.4% Less Arrow -124.4%
Current ratio 119.6% More Arrow 695.1% Less Arrow 313.3%
Return on equity (ROE) -884.3% More Arrow -101.5% Less Arrow -181.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Less Arrow -1 Equal arrow -1
Chg. No. of employees % 0% Less Arrow -17% More Arrow -14%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.